|
Search
Collections
Benchmarks
Upload document
Organization
Guy’s Hospital
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
2 posters
Poster
First-in-human study of BLU-554, a potent, highly selective FGFR4 inhibitor designed for hepatocellular carcinoma (HCC) with FGFR4 pathway activation
Poster
First-in-human study of BLU-554, a potent, highly selective FGFR4 inhibitor designed for hepatocellular carcinoma (HCC) with FGFR4 pathway activation